norethindrone has been researched along with fibrinogen in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (54.84) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 10 (32.26) | 29.6817 |
| 2010's | 2 (6.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chakrabarti, R; Haines, AP; Howarth, DJ; Meade, TW; North, WR; Stirling, Y | 1 |
| Allen, DG; Heywood, R; Hossack, DJ; Sortwell, RJ; Wadsworth, PF; Walton, RM | 1 |
| Chen, AJ; Fotherby, K; Jiang, HY; Lu, FY; Meng, YX; Shao, QX; Shen, KY; Sun, DL; Yang, H; Zhang, MY | 1 |
| Bonnar, J | 1 |
| Barbosa, J; Doe, RP; Seal, US | 2 |
| Poller, L; Thomas, PW; Thomson, JM | 1 |
| Khowessah, MM; Malek, AT; Medhat, IA; Moghazi, M; Rizk, MA; Toppozada, HK | 1 |
| Chandra, RK | 1 |
| Glueck, CJ; Glueck, HI | 1 |
| Coopland, AT; Wodzicki, AM | 1 |
| Astrup, T; Brakman, P; Sobrero, AJ | 1 |
| Ambrus, JL; Courey, NG; Mink, IB; Niswander, KR; Wamsteker, EF | 1 |
| Albrechtsen, OK; Astrup, T; Brakman, P | 1 |
| Chua, SE; Evatt, BL; Koh, S; Layde, P; Ratnam, SS; Tsakok, FH; Tyler, CW | 1 |
| Brenner, PF; de Quattro, V; Dozono-Takano, R; Eide, I; Gray, G; Mishell, DR; Roy, S; Shaw, ST | 1 |
| Borkenstein, M; Muntean, W | 1 |
| de la Iglesia, F; Fitzgerald, J; Goldenthal, EI | 1 |
| Donnez, J; Grandjean, P; Lavenne, E; Schlit, AF | 1 |
| Bulent Tiras, M; Darney, PD; Fener, N; Guner, H; Noyan, V; Yildirim, M | 1 |
| Arndt, T; Bonnar, J; Creatsas, G; Depypere, H; Erenus, M; Nickelsen, T; Quail, D; Rechberger, T | 1 |
| Berry, K; Burger, HG; Davis, SR; Goldstat, R; Koch, K; Meredith, I; Newman, A | 1 |
| Aktepe, O; Altindis, M; Fenkci, S; Fenkci, V; Kurtay, G; Sonmezer, M; Yilmazer, M | 1 |
| Borgfeldt, C; Li, C; Samsioe, G | 1 |
| Durrington, PN; Kwok, S; Laing, I; Mackness, B; Mackness, MI; McElduff, P; Morgan, J; Prais, H; Sci, FM; Selby, PL; Yates, AP | 1 |
| Gursel, T; Gursoy, R; Himmetoglu, O; Karabulut, E; Onan, MA; Ozpolat, E; Taner, MZ; Taskiran, C | 1 |
| Brosnan, JF; Norris, LA; Sheppard, BL | 1 |
| Archer, DF; Gut, R; Lang, E; Panay, N; Ylikorkala, O | 1 |
| Bingol, B; Biri, A; Gunenc, Z; Güner, H; Tiras, B; Yilmaz, M | 1 |
| Brosnan, JF; Kelly, LA; Norris, LA; O'Leary, JJ; Sheppard, BL | 1 |
15 trial(s) available for norethindrone and fibrinogen
| Article | Year |
|---|---|
Hemostatic changes in women using a monthly injectable contraceptive for one year.
Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Estradiol; Factor VIII; Factor X; Female; Fibrinogen; Follicular Phase; Hemoglobins; Humans; Injections, Intramuscular; Leukocyte Count; Longitudinal Studies; Luteal Phase; Norethindrone; Prospective Studies; Prothrombin Time | 1990 |
Effects of steroids on plasma proteins--progestational agents.
Topics: Adolescent; Adult; Alpha-Globulins; Androgen Antagonists; Animals; Blood Proteins; Chlormadinone Acetate; Clinical Trials as Topic; Contraceptives, Oral; Dydrogesterone; Ethisterone; Female; Fibrinogen; Glucuronidase; Haplorhini; Haptoglobins; Humans; Hydrocortisone; Male; Medroxyprogesterone; Norethindrone; Plasminogen; Pregnanes; Progesterone; Thromboembolism; Thyroxine-Binding Proteins; Transcortin; Trypsin Inhibitors | 1971 |
Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Topics: Adolescent; Adult; Alkaline Phosphatase; Angiotensin II; Antithrombin III; Aspartate Aminotransferases; Bilirubin; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Levonorgestrel; Mestranol; Norethindrone; Norgestrel; Thromboembolism; Transcortin; Triglycerides | 1980 |
Large increase in plasmatic 11-dehydro-TxB2 levels due to oral contraceptives.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Analysis of Variance; Contraceptives, Oral; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrinogen; Humans; Levonorgestrel; Norethindrone; Norgestrel; Prothrombin; Thromboxane B2 | 1995 |
Effects of a monthly injectable steroidal contraceptive, Mesigyna, on menstrual pattern, lipoproteins, and coagulation parameters.
Topics: Adolescent; Adult; Bilirubin; Blood Coagulation; Cholesterol; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Fibrinogen; Humans; Injections; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Menstruation; Norethindrone; Partial Thromboplastin Time; Prothrombin Time; Serum Albumin; Triglycerides | 2001 |
Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
Topics: Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Europe; Female; Fibrinogen; Humans; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Triglycerides | 2001 |
Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
Topics: Aged; Anticholesteremic Agents; Brachial Artery; Cholesterol, HDL; Cholesterol, LDL; Diet, Reducing; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Hypercholesterolemia; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Pravastatin; Progesterone Congeners; Quality of Life; Reference Values; Regional Blood Flow | 2002 |
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin | 2003 |
Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women.
Topics: Administration, Cutaneous; Administration, Oral; Adult; C-Reactive Protein; Cross-Sectional Studies; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause | 2003 |
Low-dose oral combination of 17beta-estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1.
Topics: Administration, Oral; Aged; Antithrombins; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Postmenopause | 2004 |
Progestogens of varying androgenicity and cardiovascular risk factors in postmenopausal women receiving oestrogen replacement therapy.
Topics: Aryldialkylphosphatase; Biomarkers; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Desogestrel; Drug Administration Schedule; Estrogen Replacement Therapy; Female; Fibrinogen; Humans; Insulin; Lipoproteins; Medroxyprogesterone; Middle Aged; Norethindrone; Postmenopause; Progestins; Risk Factors; Statistics, Nonparametric; Triglycerides | 2004 |
Effects of four different regimens of hormone replacement therapy on hemostatic parameters: a prospective randomized study.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Fibrinogen; Hemostasis; Humans; Hysterectomy; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Treatment Outcome | 2006 |
Haemostatic activation in post-menopausal women taking low-dose hormone therapy: less effect with transdermal administration?
Topics: Administration, Cutaneous; Administration, Oral; Aged; alpha-2-Antiplasmin; Antigens; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Fibrinolysin; Fibrinolysis; Humans; Ireland; Middle Aged; Norethindrone; Norethindrone Acetate; Peptide Fragments; Postmenopause; Prothrombin; Risk Factors; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2007 |
Ultra-low-dose estradiol and norethisterone acetate: effective menopausal symptom relief.
Topics: Adult; Aged; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Double-Blind Method; Estradiol; Estrogen Replacement Therapy; Factor VII; Female; Fibrinogen; Hot Flashes; Humans; Hydrogen-Ion Concentration; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Severity of Illness Index; Vagina | 2007 |
Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Topics: Biomarkers; Blood Glucose; C-Reactive Protein; Carbohydrate Metabolism; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Estrogens; Female; Fibrinogen; Homocysteine; Humans; Inflammation; Lipid Metabolism; Lipoproteins; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Risk Factors | 2010 |
16 other study(ies) available for norethindrone and fibrinogen
| Article | Year |
|---|---|
Haemostatic, lipid, and blood-pressure profiles of women on oral contraceptives containing 50 microgram or 30 microgram oestrogen.
Topics: Adult; Antithrombins; Blood Coagulation; Blood Pressure; Cholesterol; Contraceptives, Oral; Estradiol Congeners; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Humans; Lipids; Norethindrone; Norgestrel; Prothrombin; Triglycerides | 1977 |
Treatment of rhesus monkeys (Macaca mulatta) with intravaginal rings impregnated with either progesterone or norethisterone.
Topics: Animals; Dose-Response Relationship, Drug; Female; Fibrinogen; Haplorhini; Intrauterine Devices, Medicated; Leukocytes; Macaca mulatta; Mucous Membrane; Norethindrone; Progesterone; Uterine Hemorrhage; Vagina | 1979 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
Effects of progestogen oral contraception with norethisterone on blood clotting and platelets.
Topics: Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Chlormadinone Acetate; Contraceptives, Oral; Drug Combinations; Estrogens; Factor VII; Factor X; Female; Fibrinogen; Humans; Norethindrone; Phosphatidylethanolamines; Platelet Adhesiveness; Postpartum Period; Pregnancy; Progestins; Prothrombin Time | 1972 |
Anti-estrogens and plasma proteins. II. Contraceptive drugs and gestagens.
Topics: Adolescent; Adult; Animals; Blood Proteins; Chlormadinone Acetate; Contraceptives, Oral; Cyproterone; Dydrogesterone; Ethinyl Estradiol; Female; Fibrinogen; Haplorhini; Haptoglobins; Humans; Hydrocortisone; Male; Norethindrone; Norgestrel; Plasminogen; Thyroxine; Thyroxine-Binding Proteins; Transferrin | 1973 |
A study of the effect of an oral contraceptive on blood coagulation factors, platelets and fibrinolytic activity.
Topics: Adult; Blood Cell Count; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Clot Retraction; Drug Combinations; Ethinyl Estradiol; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Fibrinolysis; Humans; Norethindrone; Parity; Platelet Adhesiveness; Prothrombin; Time Factors | 1974 |
Serum levels of IgG and -macroglobulin and incidence of cryofibrinogenaemia in women taking oral contraceptives.
Topics: Blood Protein Disorders; Cold Temperature; Contraceptives, Oral; Female; Fibrinogen; Humans; Immune Sera; Immunodiffusion; Immunoglobulin G; Immunoglobulins; Lynestrenol; Macroglobulins; Mestranol; Norethindrone | 1972 |
Clotting mechanisms in patients with hypertriglyceridemia during therapy with anabolic or progestational drugs.
Topics: Adenosine Diphosphate; Blood Coagulation; Cholesterol; Electrophoresis, Paper; Factor IX; Factor V; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperlipidemias; Male; Norethindrone; Oxandrolone; Prothrombin; Prothrombin Time; Thrombin; Triglycerides | 1973 |
Effect of lactation suppressants on the coagulation mechanism.
Topics: Adolescent; Adult; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets; Estrogens; Factor IX; Factor VII; Factor VIII; Factor X; Female; Fibrinogen; Humans; Lactation; Mestranol; Naphthalenes; Norethindrone; Platelet Adhesiveness; Postpartum Period; Pregnancy; Prothrombin Time; Thromboplastin; Time Factors; Valerates | 1974 |
Effects of different systemic contraceptives on blood fibrinolysis.
Topics: Adult; Algestone Acetophenide; Blood Coagulation Tests; Contraceptives, Oral; Estradiol; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Fibrinogen; Fibrinolysis; Humans; Medroxyprogesterone; Mestranol; Middle Aged; Norethindrone; Norethynodrel; Plasminogen; Pregnancy; Pregnanes; Progestins | 1970 |
Progestational agents and blood coagulation. II.
Topics: Acetates; Adolescent; Adult; Blood Coagulation; Blood Coagulation Tests; Contraceptives, Oral; Ethinyl Estradiol; Factor X; Female; Fibrinogen; Fibrinolysis; Humans; Norethindrone; Plasminogen; Prothrombin; Thromboembolism | 1969 |
Blood coagulation, fibrinolysis, and contraceptive hormones.
Topics: Adolescent; Adult; Aged; Blood Coagulation; Estrogens; Female; Fibrinogen; Fibrinolysis; Fibrinolytic Agents; Humans; Male; Menopause; Mestranol; Middle Aged; Norethindrone; Plasminogen; Progesterone; Prothrombin Time; Sex | 1967 |
Effects of norethisterone on coagulation and fibrinolysis in Asian women.
Topics: Blood Coagulation; Endometriosis; Female; Fibrinogen; Fibrinolysis; Humans; Norethindrone; Platelet Count | 1984 |
Haemostatic changes in tall girls treated with high doses of ethinyloestradiol.
Topics: Adolescent; Blood Coagulation; Body Height; Ethinyl Estradiol; Factor VIII; Female; Fibrinogen; Growth Disorders; Humans; Norethindrone; Platelet Adhesiveness; Thrombin Time | 1980 |
Ten-year oral toxicity study with Norlestrin in rhesus monkeys.
Topics: Animals; Blood Coagulation; Blood Glucose; Body Weight; Carcinogens; Contraceptives, Oral; Contraceptives, Oral, Combined; Drug Combinations; Ethinyl Estradiol; Factor X; Female; Fibrinogen; Macaca mulatta; Norethindrone; Platelet Count; Prothrombin Time; Steroids; Time Factors | 1982 |
Norethisterone acetate alters coagulation gene expression in vitro in human cell culture.
Topics: Blood Coagulation; Cells, Cultured; Contraceptives, Oral, Synthetic; Estradiol; Estrone; Factor VII; Fibrinogen; Gene Expression Regulation; Hepatocytes; Human Umbilical Vein Endothelial Cells; Humans; Lipoproteins; Norethindrone; Norethindrone Acetate; Plasminogen Activator Inhibitor 1; Prothrombin; Real-Time Polymerase Chain Reaction; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thromboplastin; Time Factors; Tissue Plasminogen Activator | 2013 |